Global /China /Healthcare /Medical Distribution /600332
chevron_leftBack

Guangzhou Baiyunshan Pharmaceutical Holdings Company Ltd.

600332
SSE: 600332 Delayed
26.07CNY -0.7%
3.58 USD
As of 24 April 2025, Guangzhou Baiyunshan Pharmaceutical Holdings Company Ltd. has a market cap of $5.51B USD, ranking #2638 globally and #382 in China. It ranks #229 in the Healthcare sector, and #8 in the Medical Distribution industry.
Global Rank
2638
Country Rank
382
Sector Rank
229
Industry Rank
8
Key Stats
Market Cap
$5.51BUSD
40.14B CNY
Enterprise Value
$4.55BUSD
33.16B CNY
Revenue (TTM)
$10.29BUSD
74.99B CNY
EBITDA (TTM)
$558.29MUSD
4.07B CNY
Net Income (TTM)
$389.12MUSD
2.84B CNY
EBITDA Margin
5.4%
Profit Margin
3.8%
PE Ratio
14.2
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Medical Distribution
CEO
Hong Li open_in_new
Employees
28,048
Founded
1997
Website
gybys.com.cn open_in_new
warningChart data may be delayed
1d 1w 1m 3m 6m 1y
-0.7% -1.1% -2% -2.4% -9.4% -17%
Upcoming Earnings
Earnings Date
Wed, Apr 30

Markets

Exchange Ticker Price
Shanghai Stock Exchange
MIC: XSHG
PRIMARY
600332
广州白云山医药集团股份有限公司 Class A
ISIN: CNE000001733
Shares Out.:
1.406B1 Shares Float: 541.468M2
TV:
SA:
YF:
GF:
BA:
MS:
26.07 CNY
Hong Kong Stock Exchange
MIC: XHKG
874
广州白云山医药集团股份有限公司 Class H
ISIN: CNE100000387
Shares Out.:
219.9M1 Shares Float: 219.9M2
TV:
SA:
YF:
GF:
BA:
874
MS:
16.82 HKD
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About Guangzhou Baiyunshan Pharmaceutical Holdings Company Ltd.

Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited, together with its subsidiaries, researches, develops, manufactures, and sells Chinese patent and Western medicines, chemical raw materials, natural and biological medicines, and intermediates of chemical raw materials in the People’s Republic of China and internationally. The company operates through Great Southern TCM, Great Commerce, Great Health, and Other segments. It is also involved in the wholesale, retail, sale, import, and export of Western and Chinese medicines, medical instruments, pharmaceutical products, medical equipment, and healthcare products; and research and development, production, and sale of beverages, food, healthcare products, and other products; and production and sale of pre-packaged food, dairy products, etc., as well as offers herbal tea, tablets, capsules, lozenges, tortoise herb jelly, etc. In addition, the company invests in health industry, such as medical services, health management, health maintenance, elderly care, etc.; and provides leasing and commercial, health, advertising, loading offloading, and warehouse services. It operates through retail chain pharmacy stores and retail stores. The company was formerly known as Guangzhou Pharmaceutical Company Limited and changed its name to Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited in August 2013. Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited was incorporated in 1997 and is based in Guangzhou, China.

Similar Companies

Industry: Medical Distribution (China)
Name
Market Cap diff.
Shanghai Pharmaceuticals Holding Co., Ltd.
601607
$8.27B
60.23B CNY
50%
Sinopharm Group Co. Ltd.
1099
$7.18B
55.73B HKD
30%
Jointown Pharmaceutical Group Co., Ltd.
600998
$3.3B
24.02B CNY
-40%
China National Medicines Corporation Ltd.
600511
$3.05B
22.23B CNY
-45%
China Meheco Group Co., Ltd.
600056
$2.08B
15.14B CNY
-62%
Industry: Medical Distribution (Global)
Name
Market Cap diff.
McKesson Corp.
MCK
$86.84B
1K%
Cencora, Inc.
COR
$55.21B
902%
Cardinal Health, Inc.
CAH
$32.48B
490%
SIGMA HEALTHCARE Ltd.
SIG
$21.56B
33.88B AUD
291%
Henry Schein, Inc.
HSIC
$8.02B
46%